Genomes and Genes
Role of plasminogen activator inhibitor-1 in mediating age-related fibrosis
Principal Investigator: David Lu
Abstract: DESCRIPTION (provided by applicant): Cardiovascular aging results in cardiac fibrosis, diastolic dysfunction, and attenuated wound healing post-myocardial infarction (MI). While numerous studies have correlated increases in plasminogen activator inhibitor-1 (PAI-1) with aging, none have directly examined possible mechanisms of PAI-1-mediated inhibition of collagen turnover. The proposed study seeks to identify a role of PAI-1 in regulating age-related cardiac fibrosis. Age-dependent increases of PAI-1 correlate with decreased matrix metalloprotease (MMP) activity, increased collagen deposition, and blunted inflammatory response. As a consequence of impaired ECM degradation and fibroblast migration, the reduction in MMP activity may cause ventricular fibrosis by increasing collagen deposition and diminished inflammatory responses post-MI. Isolated rat cardiac fibroblasts (CFs) will be used to investigate the relationship between PAI-1 release and potential effects on collagen deposition and CF migration. The first aim of this study asks whether PAI-1 produced and released by CFs increases collagen deposition by inhibiting MMP activation. Total and active MMPs will be assayed in CFs by Western blotting, zymography, and ELISA. The second aim compares PAI-1 expression in CFs isolated from young and aged rats to examine whether expression increases with age and is responsible for increased collagen accumulation. The increase of PAI-1 with age is hypothesized to attenuate MMP activity. This in turn decreases collagen degradation and may also inhibit CF migration. Finally, the third aim of the study will use an ex vivo rat ischemia-reperfusion model. This provides a system to ascertain whether PAI-1 expression is increased basally in aged hearts and whether PAI-1 is up-regulated in physiologically relevant concentrations following ischemic stress. Acute inhibition of MMP activity by PAI-1 may explain the attenuated inflammatory and wound healing responses post-MI seen in aged individuals. Together, these findings may identify a novel PAI-1 dependent mechanism in which aged hearts are more prone to both fibrosis and attenuated wound healing following ischemic damage.
Funding Period: 2012-01-01 - 2013-06-30
more information: NIH RePORT
- ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptorsDavid Lu
Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA
FASEB J 26:2580-91. 2012..Thus, ATP release activates P2Y(2) receptors to mediate profibrotic responses in CFs, implying that nucleotide release under both basal and activated states is likely an important mechanism for fibroblast homeostasis...
- Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblastsDavid Lu
Department of Pharmacology, University of California at San Diego, La Jolla, California 92093, USA
J Biol Chem 288:19040-9. 2013..These findings also imply that cellular homeostasis and fibrotic response involve the integration of signaling that is pro-fibrotic by ATP and anti-fibrotic by adenosine and that is regulated by ENTPDs. ..
- Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosisDavid Lu
Departments of Pharmacology D L, N A, U Y, P A I and Medicine P A I, University of California, San Diego, La Jolla, California Veterans Affairs San Diego Healthcare System, San Diego, California H H P Department of Anesthesiology, University of California, San Diego, La Jolla, California H H P and Cardiovascular Research Institute, Yokohama City University, Yokohama, Japan U Y
Mol Pharmacol 84:787-93. 2013..We conclude that therapeutic strategies designed to enhance cellular cAMP concentrations in CFs may provide a means to reverse excessive scar formation following injury and to treat cardiac fibrosis. ..
- Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisDavid Lu
Department of Pharmacology, University of California, San Diego, La Jolla, California and
Am J Physiol Cell Physiol 306:C779-88. 2014..This review summarizes recent findings related to purinergic signaling in the regulation of fibroblasts and the development of tissue fibrosis in the heart, lungs, liver, and kidney...
- Mental Stress Ischemia: Prognosis and Genetic InfluencesArshed A Quyyumi; Fiscal Year: 2013....
- CARDIOVASCULAR DYNAMICS AND THEIR CONTROLJohn E Hall; Fiscal Year: 2013..End of Abstract) ..
- FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIRDavid M Ornitz; Fiscal Year: 2013..This knowledge will be essential to effectively design and implement FGF-based therapies for the treatment of human CVD. ..
- Cardioprotective Effect of Growth Hormone Releasing HormoneJoshua M Hare; Fiscal Year: 2013..This proposal has major implications for developing a promising new treatment strategy for the prevention and reversal of remodeling following MI. ..
- Extracellular matrix remodeling and fibrosisJANE M SOTTILE; Fiscal Year: 2013..These studies may lead to the development a new therapeutic approach for limiting fibrosis, for which there are few effective treatments. ..
- Restoring Mycocardial HealingMARK ALAN SUSSMAN; Fiscal Year: 2013..The goal of this program will be to delineate these deleterious signaling mechanisms and determine how they can be overcome to restore endogenous cellular repair processes that heal the damaged heart. ..
- Mechanisms of Atherogenesis in Insulin ResistanceIRA A TABAS; Fiscal Year: 2013..End of Abstract) ..
- Neutralizing Antibody &AAV FIX Gene TherapyRichard J Samulski; Fiscal Year: 2013..The long-term objective of this PPG is to advance basic understanding of vector-cell-animal model interactions for safe gene delivery. ..
- Immune-Based Interventions Against Infectious DiseasesAlan L Rothman; Fiscal Year: 2013..3. Recruit promising junior investigators and provide mentoring by established NIH-funded researchers. 4. Support a multidisciplinary research program led by junior investigators in translational infectious diseases immunology. ..
- Endothelial Injury and Repair: CardioPulmonary Vascular Biology COBRESHARON IRENE SMITH ROUNDS; Fiscal Year: 2013..abstract_text> ..
- Pathophysiology of Alveolar Epithelial Lung InjuryJacob I Sznajder; Fiscal Year: 2013..The insights gained from the data generated from these studies will provide novel molecular targets for the development of new therapeutic strategies to treat patients with lung injury. ..